Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Smith

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Environment International|October 29, 2013
Environmental estrogens in an urban aquatic ecosystem: I. Spatial and temporal occurrence of estrogenic activity in effluent-dominated systemsDalma Martinovic-Weigelt, Thomas A Minarik, Erin M Curran, et al.
Science (New York, N.Y.)|November 25, 2021
A ubiquitous disordered protein interaction module orchestrates transcription elongationKaterina Cermakova, Jonas Demeulemeester, Vanda Lux, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Scientific Reports|March 21, 2017
DEK is required for homologous recombination repair of DNA breaksEric A Smith, Boris Gole, Nicholas A Willis, et al.
Oncogene|April 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAF<sup>V600E</sup> and promotes therapy resistanceJunhua Wang, Yinshen Wee, Thomas Jacob, et al.
Nature Metabolism|June 15, 2019
Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancerDavid A Bader, Sean M Hartig, Vasanta Putluri, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Cell Reports|December 17, 2025
A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanomaYuntian Zhang, Marcus A Urquijo, Rebecca G Zitnay, et al.
JAMA Dermatology|July 30, 2020
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical BenefitDouglas Grossman, Nwanneka Okwundu, Edmund K Bartlett, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Environment International|October 29, 2013
Environmental estrogens in an urban aquatic ecosystem: I. Spatial and temporal occurrence of estrogenic activity in effluent-dominated systemsDalma Martinovic-Weigelt, Thomas A Minarik, Erin M Curran, et al.
Science (New York, N.Y.)|November 25, 2021
A ubiquitous disordered protein interaction module orchestrates transcription elongationKaterina Cermakova, Jonas Demeulemeester, Vanda Lux, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Scientific Reports|March 21, 2017
DEK is required for homologous recombination repair of DNA breaksEric A Smith, Boris Gole, Nicholas A Willis, et al.
Oncogene|April 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAF<sup>V600E</sup> and promotes therapy resistanceJunhua Wang, Yinshen Wee, Thomas Jacob, et al.
Nature Metabolism|June 15, 2019
Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancerDavid A Bader, Sean M Hartig, Vasanta Putluri, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Cell Reports|December 17, 2025
A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanomaYuntian Zhang, Marcus A Urquijo, Rebecca G Zitnay, et al.
JAMA Dermatology|July 30, 2020
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical BenefitDouglas Grossman, Nwanneka Okwundu, Edmund K Bartlett, et al.
Pageof 6